These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38649666)

  • 1. Characteristics of Different Obesity Metabolic Indexes and their Correlation with Insulin Resistance in Patients with Polycystic Ovary Syndrome.
    Feng Y; Li M; Li X; Tang Q; Li X; Ji X; Tian W; Zhang H
    Reprod Sci; 2024 Sep; 31(9):2829-2835. PubMed ID: 38649666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
    Anik Ilhan G; Yildizhan B; Pekin T
    Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
    Ramezani Tehrani F; Minooee S; Azizi F
    Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fat indices as effective predictors of insulin resistance in obese/non-obese polycystic ovary syndrome women in the Southwest of China.
    Huang X; Wang Q; Liu T; Pei T; Liu D; Zhu H; Huang W
    Endocrine; 2019 Jul; 65(1):81-85. PubMed ID: 30924083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome.
    Kulik-Kupka K; Jabczyk M; Nowak J; Jagielski P; Hudzik B; Zubelewicz-Szkodzińska B
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
    Wang H; Cao H; Cao J; Zhang L
    Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome.
    Uysal E; Tammo O; Soylemez E; Incebıyık M; Filiz D; Alci M
    BMC Endocr Disord; 2024 Aug; 24(1):160. PubMed ID: 39198818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect Predictors of Visceral Adipose Tissue in Women with Polycystic Ovary Syndrome: A Comparison of Methods.
    Kałużna M; Czlapka-Matyasik M; Bykowska-Derda A; Moczko J; Ruchala M; Ziemnicka K
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of visceral, general and central obesity indices in the prediction of metabolic syndrome in maintenance hemodialysis patients.
    Zhou C; Zhan L; Yuan J; Tong X; Peng Y; Zha Y
    Eat Weight Disord; 2020 Jun; 25(3):727-734. PubMed ID: 30968371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
    Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
    Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profile in women with polycystic ovary syndrome across adult life.
    Echiburú B; Crisosto N; Maliqueo M; Pérez-Bravo F; de Guevara AL; Hernández P; Cavada G; Rivas C; Clavel A; Sir-Petermann T
    Metabolism; 2016 May; 65(5):776-782. PubMed ID: 27085784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
    Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
    Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial.
    Amiri M; Rahmati M; Hedayati M; Nahidi F; Ramezani Tehrani F
    J Endocrinol Invest; 2021 Mar; 44(3):567-580. PubMed ID: 32681463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.
    Qing L; Wei R; Chan L; Xiaoya Z; Xin X
    J Endocrinol Invest; 2017 Jun; 40(6):653-661. PubMed ID: 28233232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index.
    Borruel S; Moltó JF; Alpañés M; Fernández-Durán E; Álvarez-Blasco F; Luque-Ramírez M; Escobar-Morreale HF
    PLoS One; 2014; 9(12):e114112. PubMed ID: 25479351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.